End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
39.92 EUR | +0.55% | +0.34% | +5.60% |
05-16 | Bernstein Adjusts Price Target on Newmont to $45 From $46, Keeps Market Perform Rating | MT |
05-10 | BNP Paribas Exane Adjusts Price Target on Newmont to $52 From $49 | MT |
Strengths
- Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
- The group's high margin levels account for strong profits.
- Over the past year, analysts have regularly revised upwards their sales forecast for the company.
- Analysts have consistently raised their revenue expectations for the company, which provides good prospects for the current and next years in terms of revenue growth.
- For several months, analysts have been revising their EPS estimates roughly upwards.
- Over the past twelve months, analysts' opinions have been strongly revised upwards.
Weaknesses
- With an enterprise value anticipated at 3.26 times the sales for the current fiscal year, the company turns out to be overvalued.
- The overall consensus opinion of analysts has deteriorated sharply over the past four months.
- Prospects from analysts covering the stock are not consistent. Such dispersed sales estimates confirm the poor visibility into the group's activity.
- The group usually releases earnings worse than estimated.
Ratings chart - Surperformance
Sector: Gold
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+5.60% | 50.41B | - | ||
+27.82% | 34.94B | B | ||
+1.63% | 31.39B | B+ | ||
+18.69% | 25.86B | B | ||
+7.62% | 11.28B | B | ||
+35.96% | 10.6B | B- | ||
+35.66% | 9.83B | A- | ||
+10.06% | 8.75B | B- | ||
-.--% | 8.71B | - | B- | |
+30.53% | 6.8B | B+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- NEM Stock
- NEWM Stock
- Ratings Newmont Corporation